Author: Ruiter Rikje Visser Loes E. van Herk-Sukel Myrthe P.P.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.35, Iss.6, 2012-06, pp. : 471-480
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pioglitazone is a Valid Alternative to Rosiglitazone
American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. :
Rosiglitazone meta-analysis: full impact on prescribing yet to be felt
Reactions Weekly, Vol. 1, Iss. 1200, 2008-01 ,pp. :
By Vlckova Veronika Cornelius Victoria Kasliwal Rachna Wilton Lynda Shakir Saad A.W.
Drug Safety, Vol. 32, Iss. 5, 2009-01 ,pp. :
Prescribing and dispensing in Japan: conflict of interest?
By Tatara Kozo
Clinical Medicine, Vol. 3, Iss. 6, 2003-11 ,pp. :